Lyron Deputy
Nurse Practitioner · Newark, DENPI 1134441702
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,922 of the $5,685 with a category attached, or 69.0%. 18 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 49.7% of the total. Reporting peaked in 2023 at $3,265 and has fallen 61.0% since, to $1,272 in 2025. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $58.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$3K
- Harmony Biosciences LLC$648
- Jazz Pharmaceuticals Inc.$550
- Axsome Therapeutics, Inc.$423
- United Therapeutics Corporation$308
- Verona Pharma, Inc.$235
- plus $696 from 12 others
What the payments were for
- Travel & lodging$1,75131%
- Food & beverage$3,92269%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 7 | $2,825 |
| Harmony Biosciences LLC | 23 | $648 |
| Jazz Pharmaceuticals Inc. | 17 | $550 |
| Axsome Therapeutics, Inc. | 15 | $423 |
| United Therapeutics Corporation | 7 | $308 |
| Verona Pharma, Inc. | 7 | $235 |
| Boehringer Ingelheim | 1 | $111 |
| Sanofi | 4 | $105 |
| GSK | 1 | $100 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $98 |
| Lilly USA, LLC | 4 | $77 |
| Inspire Medical Systems, Inc. | 1 | $51 |
| Optinose US, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| AstraZeneca | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$2,655
- XYWAV$128
- Ohtuvayre$124
- JARDIANCE$111
How this compares
$5,685 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Newark
- Sedelle Henderson-BamideleNewark$13K
- Funmilola OlaoyeNewark$7K
- Mark LandisNewark$5K
- Noreen Murphy BowensNewark$4K
- Mary ZimnyNewark$4K
- Amanda WardwellNewark$4K
- Heather DennisNewark$4K
- Anesha VictorNewark$3K
- Lori GrantNewark$3K
- Alexandra QuinnNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.